Search Login Register
zolmitriptan
(Zomig)
Summary
Description:
an antimigraine compound; a serotonin (5HT)-1D receptor agonist
Also Known As:
Zomig; 311C90; 4-((3-(2-(dimethylamino)ethyl)-1H-indol-5-yl)methyl)-2-oxazolidinone; AscoTop; Astra brand of zolmitriptan Show All >>
Networked: 246
relevant articles (62 outcomes,
97 trials/studies)
for this Drug
Key Diseases for which zolmitriptan is
Relevant
-
Migraine Disorders (Migraine)
:
53 outcomes 82 studies in 191 results
-
Headache (Headaches)
:
19 outcomes 8 studies in 69 results
-
Pain (Aches)
:
7 outcomes 7 studies in 37 results
-
Cluster Headache (Cluster Headaches)
:
5 outcomes 3 studies in 16 results
-
Epilepsy (Aura)
:
4 outcomes 5 studies in 13 results
Show All >>
Drugs Related to zolmitriptan
-
zolmitriptan (Zomig)
-
Sumatriptan (Imigran)
-
rizatriptan (Maxalt)
-
Pain-Free
-
naratriptan
-
Serotonin (5 Hydroxytryptamine)
-
almotriptan (Axert)
-
frovatriptan (Allegro)
-
Tryptamines (Triptans)
-
eletriptan (Relpax)
Show All >>
Therapies Related to zolmitriptan
-
Oral Administration
-
Aftercare (After-Treatment)
-
Ligation
-
Electrodes (Electrode)
CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.